Latest News and Press Releases

Tevogen.AI’s model drastically reduces target analysis and has the potential to generate billions in cost savings across the healthcare system by streamlining early-stage drug discovery, reducing wet...

Dublin, July 11, 2025 (GLOBE NEWSWIRE) -- The "U.S. Bioanalytical Testing Services Market Size, Share & Trends Analysis Report by Molecule (Small Molecule, Large Molecule), Test, Workflow,...

Dublin, July 02, 2025 (GLOBE NEWSWIRE) -- The "2025 U.S. Virology, Bacteriology, Parasitology and Mycology Market Forecasts and Supplier Shares: Shares, Volume and Sales Segment Forecasts for 100...

Universidade Federal de Minas Gerais (UFMG) in Brazil and the University of Florida (UF) have been named GVN Centers of Excellence.

Dublin, June 23, 2025 (GLOBE NEWSWIRE) -- The "Infectious Diseases Collaboration and Licensing Deals 2019-2025" report has been added to ResearchAndMarkets.com's offering.Fully revised and updated,...

PHM23 was one of a handful of molecules chosen by the universityBird Flu helping PHM23 gain awareness of broad-spectrum activity at a university level BOSTON, MASSACHUSETTS, May 21, 2025 (GLOBE...

Dublin, Dec. 30, 2024 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market...

Dublin, Nov. 11, 2024 (GLOBE NEWSWIRE) -- The "Infectious Diseases Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Fully revised and updated,...

Tevogen Bio CEO Expresses Optimism About the Company’s Scientific Breakthrough in Mainstreaming Cell Therapy

WARREN, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...